BANF 68.86 Bancfirst Corp $BANF Hit a 52 week high of 68.98

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
BANF 68.86 Bancfirst Corp $BANF Hit a 52 week high of 68.98 Closing the day 09:43 at 68.86 -0.47 -0.68% With a day low of 68.43 and a total volume of 7,997.

BANF Recent Posts: http://investorshangout.com/BancFirst-Corp-BANF-53447/

BANF Bancfirst Corp Recent Headline News

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
ACW: 4.91 (+0.04), BAH: 26.45 (+0.25), BEAT: 8.42 (+0.15), BANF: 68.44 (-0.89), CLRO: 9.50 (-0.28)

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
ACMP: 62.29 (+0.55), AEO: 13.78 (-0.02), BANF: 68.44 (-0.89), BBNK: 23.21 (-0.09), BRK.B: 145.96 (+0.44)

Downgrade Alert for Bancfirst (BANF)
Comtex SmarTrend(R) - Mon Oct 20, 7:12AM CDT
Bancfirst (NASDAQ:BANF) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $63.72 on volume of 25,000 shares, above average daily volume of 20,000. BancFirst Corporation is a bank holding company owning or controlling one or more banks.
BANF: 68.44 (-0.89)

BancFirst: Looks Like A Decent Post-Earnings Play
Investment Standard - at Seeking Alpha - Sat Oct 18, 4:50PM CDT

BANF: 68.44 (-0.89)

BancFirst Corporation beats by $0.24, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:35PM CDT

BANF: 68.44 (-0.89)

BancFirst Corporation Reports Third Quarter Earnings
PR Newswire - Thu Oct 16, 3:30PM CDT
BancFirst Corporation (NASDAQ GS:BANF) reported net income of $18.8 million, or $1.19 diluted earnings per share, for the third quarter of 2014, compared to net income of $14.5 million or $0.93 diluted earnings per share, for the third quarter of 2013. Net income for the first nine months of 2014 was $48.1 million, or $3.05 diluted earnings per share, compared to $40.5 million or $2.61 diluted earnings per share, for the nine months ended September 30, 2013.
BANF: 68.44 (-0.89)

Shares of BANF Up 15.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 19, 11:12AM CDT
SmarTrend identified an Uptrend for Bancfirst (NASDAQ:BANF) on April 21st, 2014 at $58.68. In approximately 5 months, Bancfirst has returned 15.08% as of today's recent price of $67.53.
BANF: 68.44 (-0.89)

Bancfirst Up 10.5% Since SmarTrend Uptrend Call (BANF)
Comtex SmarTrend(R) - Fri Sep 12, 9:59AM CDT
SmarTrend identified an Uptrend for Bancfirst (NASDAQ:BANF) on April 21st, 2014 at $58.68. In approximately 5 months, Bancfirst has returned 10.46% as of today's recent price of $64.82.
BANF: 68.44 (-0.89)

BancFirst Corporation Issues Statement On Trading Activity
PR Newswire - Fri Aug 29, 10:43AM CDT
BancFirst Corporation (NASDAQ GS:BANF) has issued a statement regarding recent unusually high trading activity and increased market price of its 7.20% Cumulative Trust Preferred Securities, traded under the symbol BANFP. In a filing with the SEC on a Form 8-K, the company stated that the unusual activity appears to have begun in August, and it does not know of any reason for, or the source of, the trading activity. The Trust Preferred Securities pay a quarterly dividend of $0.45 per share, have a stated maturity of March 31, 2034, and are callable at any time at the par value of $25 per share.
BANF: 68.44 (-0.89), BANFP: 27.91 (+0.16)

BancFirst (BANF) Reaches 52-Week High on Strong Q2 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 10:35AM CDT
Shares of BancFirst Corp. (BANF) hit a new 52-week high of $64.70 on Aug 25, riding on a strong growth momentum.
COWN: 4.20 (-0.02), CFR: 81.30 (-0.37), BANF: 68.44 (-0.89), OPB: 27.03 (-0.08)

Texas Capital (TCBI) Shows Stability on Organic Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 4:00PM CDT
On Aug 4, 2014, we issued an updated research report on Texas Capital Bancshares Inc. (TCBI). This commercial bank recently reported impressive second-quarter 2014 results.
CFR: 81.30 (-0.37), BANF: 68.44 (-0.89), OPB: 27.03 (-0.08), TCBI: 59.63 (-2.11)

Why You Shouldn't Bet Against BancFirst (BANF) Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 7:43AM CDT
BancFirst is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
BANF: 68.44 (-0.89)

BancFirst Corporation Reports Second Quarter Earnings
PR Newswire - Thu Jul 17, 3:15PM CDT
BancFirst Corporation (NASDAQ GS: BANF) reported net income of $14.7 million, or $0.92 diluted earnings per share, for the second quarter of 2014, compared to net income of $12.6 million, or $0.82 diluted earnings per share, for the second quarter of 2013. Net income for the year to-date was $29.3 million, or $1.86 per share, compared to $26.0 million, or $1.68 per share, for the first half of 2013.
BANF: 68.44 (-0.89)

Why You Need to Pay Attention to Southside Bancshares (SBSI) Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:31AM CDT
Southside Bancshares has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy. A key reason for this move has been the positive trend in the earnings estimate revisions picture.
CFR: 81.30 (-0.37), SBSI: 34.26 (-0.03), BANF: 68.44 (-0.89), PB: 60.75 (-0.34)

BOK Financial in Expansion Mode - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 10:10AM CST
On Tuesday, BOK Financial Corporation announced a deal for the acquisition of Houston-based MBM Advisors, an independent full service retirement and pension plan investment company.
BOKF: 68.19 (-0.10), SBSI: 34.26 (-0.03), BANF: 68.44 (-0.89), PB: 60.75 (-0.34)

Southwest Bancorp (OKSB) in Focus: Stock Up 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:37AM CST
Southwest Bancorp Inc. was a big mover last session, as the company saw its shares rise nearly 6% on the day.
OKSB: 17.88 (-0.04), CFR: 81.30 (-0.37), SBSI: 34.26 (-0.03), BANF: 68.44 (-0.89)

BancFirst Assumes Operations of the former Bank of Union in El Reno, Oklahoma
PR Newswire - Fri Jan 24, 3:30PM CST
BancFirst announced today that it has entered into an agreement with the Federal Deposit Insurance Corporation (FDIC) to assume operations of the former Bank of Union, with locations in El Reno, Union City and Oklahoma City.
SCHL: 35.88 (-0.03), BANF: 68.44 (-0.89)

BancFirst Corporation Reports Fourth Quarter Earnings
PR Newswire - Thu Jan 16, 3:53PM CST
BancFirst Corporation (NASDAQ GS: BANF) reported net income of $13.9 million for the fourth quarter of 2013, up from $12.3 million for the fourth quarter of 2012. Diluted earnings per share was $0.88 compared to $0.79 for the same quarter of the prior year. Net income for the year ended December 31, 2013 was $54.3 million, up from $51.9 million for 2012. Diluted earnings per share for the year was $3.49 compared to $3.36 for 2012.
BANF: 68.44 (-0.89)

Bancfirst Shares Up 24.9% Since SmarTrend's Buy Recommendation (BANF)
Comtex SmarTrend(R) - Thu Aug 22, 5:02PM CDT
SmarTrend identified an Uptrend for Bancfirst (NASDAQ:BANF) on May 20th, 2013 at $42.81. In approximately 3 months, Bancfirst has returned 24.88% as of today's recent price of $53.46.
BANF: 68.44 (-0.89)

Bancfirst Has Returned 24.1% Since SmarTrend Recommendation (BANF)
Comtex SmarTrend(R) - Thu Aug 15, 11:11AM CDT
SmarTrend identified an Uptrend for Bancfirst (NASDAQ:BANF) on May 20th, 2013 at $42.81. In approximately 3 months, Bancfirst has returned 24.08% as of today's recent price of $53.12.
BANF: 68.44 (-0.89)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 25

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 106

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 116

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 191

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading

Top 5 Most Recently Viewed Articles

Beijing's EV Export Rules Impact NIO and Li Auto Stocks

Updated Category News Views 298

Beijing Implements Stricter EV Export Regulations Affecting Stocks Recently, Chinese electric vehicle (EV) stocks NIO (NYSE: NIO) and Li Auto (NASDAQ: LI) have experienced a notable decline following announcements regarding new regulations by Beijing aimed at tightening the export of EVs. New Export Permit Requirements Effective from January 1, the Ministry of Commerce in...

Continue Reading
OceanaGold Set to Announce Q2 2025 Financial Results Soon

Updated Category News Views 122

Upcoming Financial Results from OceanaGold OceanaGold Corporation (TSX: OGC, OTCQX: OCAND) is gearing up to release its operational and financial results for the second quarter of 2025. This detailed announcement will take place after the market close, and it’s expected to shed light on the company's recent performance and highlight future prospects. Conference Call...

Continue Reading
India's July Industrial Growth Surpasses Expectations by 0.1%

Updated Category News Views 121

India's Industrial Output Shows Promising Growth in July Recent government data reveals that India's industrial output rose by a noteworthy 4.8% year-on-year in July. This figure has drawn attention since it slightly exceeds economists' forecast of 4.7% for the same month. These growing numbers reflect a resilient manufacturing sector that is steadily recovering....

Continue Reading
VideoAmp Extends Partnership with Paramount Global for Measurement

Updated Category News Views 180

VideoAmp and Paramount Global Strengthen Their Collaboration VideoAmp, a pioneering media measurement company, has recently announced the continuation of its long-term collaboration with Paramount Global. This partnership reflects a commitment to evolving the advertising landscape with precise audience insights. Comprehensive Audience Measurement This renewal provides...

Continue Reading
Empire State Realty Trust Delivers Strong Q3 Performance and Guidance

Updated Category News Views 53

Empire State Realty Trust Shows Remarkable Q3 Financial Results Empire State Realty Trust (NYSE: ESRT) demonstrated impressive financial outcomes in its most recent earnings call for the third quarter of 2024, surpassing analyst expectations significantly. The real estate investment trust revealed a Funds From Operations (FFO) totaling $69 million, translating to $0.26...

Continue Reading